Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 886 AL 900

Molecular target for neuroinflammation and pain management: transient receptor potential vanilloid 1

Chauhdary Z, Masood MS, Irfan M, Shafi A, Rafique D, Arif A, Akmal M.

Inflammopharmacology. 2026 Oct;34(10):6347-6362. doi: 10.1007/s10787-026-02385-1. Epub 2026 Sep 4.

Spatial navigation and the basal forebrain in Alzheimer's disease and other neurodegenerative diseases

Laczó M, Lerch O, Nedelska Z, Laczó J.

Trends Neurosci. 2026 Oct;49(10):886-902. doi: 10.1016/j.tins.2026.08.005. Epub 2026 Sep 5.

Creatine monohydrate supplementation for recovery from muscle disuse: Timing matters

Stout JR, Pabian PS.

Sports Med Health Sci. 2026 May 27;8(5):495-500. doi: 10.1016/j.smhs.2026.05.006. eCollection 2026 Sep.

Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trial

Paul G, Bjartmarz H, Kirkeby A, Nelander J, Smith R, Kayhanian S, Evans A, Harry B, Cutting E, Fazal S, Lao-Kaim NP, van Vliet T, Ullén S, Grubor I, Hansson O, Piccini P, Lindvall O, Björklund A, Widner H, Parmar M, Barker RA.

Nat Med. 2026 Sep;32(9):3449-3457. doi: 10.1038/s41591-026-04525-0. Epub 2026 Jul 9.

Full recovery after severe bacterial encephalitis and brain abscess following deep brain stimulation surgery for Parkinson's disease

Rouleau EA, Falck DE, Hoffmann CF, Geraedts VJ, Zutt R, van der Gaag NA, Contarino MF.

J Parkinsons Dis. 2026 Sep;16(6):1347-1350. doi: 10.1177/1877718X261470302. Epub 2026 Jul 30.

Efficacy of citicoline as an add-on therapy in Parkinson's disease: a randomized, double-blind trial

Marano M, Pilotto A, Logroscino G, Stefani A, D'Amelio M, Difruscolo O, Barbagallo M, Barone P, Stocchi F, Kiferle L, Antonini A, Donzuso G, Grimaldi L, Ronga B, Centonze D, Sucapane P, Di Marzio F, Marano P, Mascia MM, Magistrelli L, Gambardella A, Di Lazzaro V, Magliozzi A, Urso D, Pierantozzi M, Davì C, Reggiardo G, Gaglianone M, Nicolini G, Padovani A; CITIPARK Study Group.

Parkinsonism Relat Disord. 2026 Sep;150:108911. doi: 10.1016/j.parkreldis.2026.108911. Epub 2026 Jul 29.

Glial fibrillary acidic protein in progressive supranuclear palsy: A systematic review and meta-analysis

Magro G, Laterza V, Mechelli A, Tosto F, Longo A, Camastra C, Quattrone A.

J Neurol Sci. 2026 Nov 15;490:126162. doi: 10.1016/j.jns.2026.126162. Epub 2026 Sep 4.

Convergent vulnerability and divergent outcomes of the dopaminergic system in Parkinson's and Alzheimer's diseases

Xi YT, Jia CX, Wang HD, Liu PY, Li P, Niu Q, Yin YL.

Ageing Res Rev. 2026 Sep 6;122:103358. doi: 10.1016/j.arr.2026.103358. Online ahead of print.

Potential Vitamin B6 Depletion During Carbidopa/Levodopa Therapy in Parkinson's Disease: A Scoping Review of Direct Evidence

Sielaff P, Lis M, Pawłasek J, Koch RR, Sucharski M, Michałowicz B, Cierpiał P, Puziuk M, Mikołajczak P, Staranowicz A, Dziurzyńska M, Dziurzyński P, Kiełbasiewicz M, Piwar H.

Cureus. 2026 Aug 7;18(8):e114123. doi: 10.7759/cureus.114123. eCollection 2026 Aug.

The neutrophil-to-lymphocyte ratio in Parkinson's disease: a systematic review and meta-analysis of its association with differential diagnosis, severity, and prognosis

Cabanillas-Lazo M, Montes-Baldarrago A, Uriol-Alvino S, Baltazar-Ñahui H, Pereda-Leon NB, Jimenez-Alvarez H, Mayta-Tovalino F.

Clin Park Relat Disord. 2026 Aug 15;15:100494. doi: 10.1016/j.prdoa.2026.100494. eCollection 2026.

Japanese translation of lindop parkinson's disease mobility assessment (LPA): validity and reliability study

Taniguchi S, Marumoto K, Narita M, Kawami Y, Kozuki T, Matsuda T, Miura K, Ge L, Okada Y, Ikenaka K.

Neurol Sci. 2026 Sep 8;47(10):765. doi: 10.1007/s10072-026-09370-0.

The Role of Probiotics in Parkinson's Disease - Current Evidence and Future Perspectives

Dadak Yıldırım E, Yıldırım İG.

J Diet Suppl. 2026 Sep 8:1-20. doi: 10.1080/19390211.2026.2729425. Online ahead of print.

Clinical applications of invasive spinal cord stimulation in neurological disorders: a narrative review

He M, Tan Y, He Z, Yu S, Zhang C, Deng Y.

Front Neurol. 2026 Aug 26;17:1872091. doi: 10.3389/fneur.2026.1872091. eCollection 2026.

Regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathies

Stephenson D, Concha-Marambio L, Lanz T, Merchant K, Brockmann K, King N, Carrillo L, Pedata A, Kocherla H, Hutten SJ; Critical Path for Parkinson's Consortium.

J Parkinsons Dis. 2026 Sep;16(6):1296-1312. doi: 10.1177/1877718X261463936. Epub 2026 Jul 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias